Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
22.47
-0.40 (-1.75%)
Dec 20, 2024, 4:00 PM EST - Market closed
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $1.10 billion as of December 20, 2024. Its market cap has increased by 136.80% in one year.
Market Cap
1.10B
Enterprise Value
806.12M
1-Year Change
136.80%
Ranking
Category
Stock Price
$22.47
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $1.10B, an increase of 12.71%. That is a compound annual growth rate of 6.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 1.10B | 92.48% |
| Dec 29, 2023 | 570.37M | -41.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Establishment Labs Holdings | 1.12B |
| Innoviva | 1.12B |
| Syndax Pharmaceuticals | 1.12B |
| Pulse Biosciences | 1.11B |
| CareDx | 1.11B |
| ARS Pharmaceuticals | 1.09B |
| Pharvaris | 1.06B |
| Rocket Pharmaceuticals | 1.05B |